Formalizing an integrative, multidisciplinary cancer therapy discovery workflow - Wikidata - awgldk - TriplyDB

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

http://www.wikidata.org/entity/Q33693626

about

Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.Metronomics: towards personalized chemotherapy?Mathematical modeling for novel cancer drug discovery and development.Fighting Cancer with Mathematics and Viruses.A Model for Spheroid versus Monolayer Response of SK-N-SH Neuroblastoma Cells to Treatment with 15-Deoxy-PGJ2.Computational modeling in melanoma for novel drug discovery.Role of vascular normalization in benefit from metronomic chemotherapy.

P2860

Q26799987-9BBEFA95-66FE-4ADE-B652-52154860CC07 Q26827129-28DC503D-4D64-4485-9945-77681ED55D1E Q33861540-A3DD0862-6C8A-4739-A135-6C11CA6F2FBF Q38218923-D1358C7D-8377-4370-9292-7CF92689B196 Q38233988-409C2EE8-064D-4524-A69E-4C387B798928 Q38612646-D0BDFCB8-71D1-4861-A58B-1217F1C1EC35 Q38723201-449C5B5B-3426-49C5-ADF8-2346234107CB Q38798578-A2D9CF71-8994-489B-95BF-4ADD539F0E49 Q42318133-201EA922-F0CC-4C53-9C2E-E92A28442FCC

P2860

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

http://www.wikidata.org/entity/Q33693626

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

@ast

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

@en

type

label

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

@ast

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

@en

prefLabel

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

@ast

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

@en

P1433

Q33693626-87EB806E-569B-4584-9053-EF8E9218AE8E

P1476

Q33693626-4DB89AF4-17AB-4E1A-B260-09B2F751BF4A

P2093

Q33693626-1EEB3519-FD86-4DF8-A4C4-350EF863267C

Q33693626-49BD2251-D210-4DBF-99E1-BF1994E78F43

Q33693626-54868A1A-66DE-4E4D-AE71-516EE9F5437F

Q33693626-71D43B10-91A3-4A58-863D-8DFA9A1E564A

Q33693626-88A4205A-472B-412C-ADA4-836BF855FB0F

Q33693626-B7CC8515-EC3F-405A-B14D-82B83DBF06E2

Q33693626-E5BA3ED0-0378-4B6A-8F41-E37075286190

Q33693626-E87ED64E-4C78-4E0D-B6AF-5E0C3A6152A2

P2860

Q33693626-01250097-4359-432F-AC2C-C32ADF37CF6D

Q33693626-02404FA2-1079-431D-8D39-9BE29DA4580F

Q33693626-07FD275D-A969-497F-83CE-C11A9616A977

Q33693626-121FCD93-9657-4170-93FA-56F78935DBA5

Q33693626-18CA8391-DCD4-4D8B-BB09-DBCA78946F59

Q33693626-20482021-E2D2-4E5E-B5F9-A730B1F92C2E

Q33693626-2480BBFF-154B-4280-93F5-37750CC5E2F7

Q33693626-2EA1CD1D-E076-4F7B-A54E-F44607BDE3DB

Q33693626-2ECEB5FF-8F3D-49E1-B6DE-94C32CDC8444

Q33693626-2F921C2C-B82F-446F-8DDC-C01847322C07

P304

Q33693626-FEE3815C-A464-4B43-BCAA-8FA55D329687

P31

Q33693626-8966774B-FEFA-48FD-BC19-72D2C9935BD1

P356

Q33693626-ED32C6AB-5D84-48FD-AAF3-50E0474D30C7

P407

Q33693626-76C416FD-C1C9-4CD7-B71D-6339900D02EE

P433

Q33693626-3542524A-6E46-4294-98D6-460041C8BE93

P478

Q33693626-87D87C31-2386-4BD1-AFE1-EA367E52CF57

P577

Q33693626-DB2AA7BE-6099-4E6D-936B-BECC06C514C3

P698

Q33693626-4E69C589-7EC6-4AF2-9A93-AE4AAB44DB10

P921

Q33693626-17B05F73-A323-445F-B234-6FD6ABC26022

P932

Q33693626-E04DC10C-AFFF-4B74-A9EE-549B6A3C8819

P356

0008-5472.CAN-13-0310

P1433

Cancer Research

P1476

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow

@en

P2093

Dorothy I Wallace

http://www.w3.org/2001/XMLSchema#string

Eddy Pasquier

http://www.w3.org/2001/XMLSchema#string

Heiko Enderling

http://www.w3.org/2001/XMLSchema#string

Jaspreet Batra

http://www.w3.org/2001/XMLSchema#string

John C Panetta

http://www.w3.org/2001/XMLSchema#string

Marie Jordan

http://www.w3.org/2001/XMLSchema#string

Mary F McGuire

http://www.w3.org/2001/XMLSchema#string

Sushil Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Patient-derived tumour xenografts as models for oncology drug development

Metformin in cancer: translational challenges

What is the evidence that tumors are angiogenesis dependent?

Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: a case study with acetaminophen.

Using pharmacokinetic and pharmacodynamic modeling and simulation to evaluate importance of schedule in topotecan therapy for pediatric neuroblastoma.

The several Cs of translational clinical research

Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?

Targeted expression of MYCN causes neuroblastoma in transgenic mice.

Team research at the biology-mathematics interface: project management perspectives.

P304

6111-6117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-13-0310

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23955390

http://www.w3.org/2001/XMLSchema#string

P921

P932

4040396

http://www.w3.org/2001/XMLSchema#string